Actinogen Medical Limited (ASX: $ACW) has requested a trading halt pending an announcement regarding a fund raising. The halt is expected to remain in place until the release of the announcement or no later than 10.00 am AEST on Friday, 3 May 2024.
The Company, Actinogen Medical Limited, has requested a trading halt in accordance with ASX Listing Rule 17.1, pending an announcement related to a fund raising. The halt is anticipated to be in effect until the release of the announcement or no later than 10.00 am AEST on Friday, 3 May 2024. The Company is not aware of any reason why the trading halt should not be granted by ASX Limited.
Actinogen Medical Limited (ASX: $ACW) has requested a trading halt in preparation for an announcement regarding a fund raising. The halt is expected to be lifted upon the release of the announcement or by 10.00 am AEST on Friday, 3 May 2024. This trading halt indicates the Company's intention to disclose significant information to the market, potentially impacting its corporate strategy and financial position. Investors and stakeholders should await the forthcoming announcement for further insights into Actinogen Medical's future plans and initiatives.